Categories : Anti-Infectives
Product Packaging : 1 vial each
Product Composition : 500 mg / 1000 mg / 2000 mg
Send MessageGenliva Wellness LLP develops Imipenem & Cilastatin Injection for life-threatening bacterial infections requiring broad-spectrum carbapenem antibacterial therapy in hospital and critical care environments. The formulation is frequently administered in septicemia, lower respiratory tract infections, intra-abdominal infections, complicated urinary tract infections, and mixed bacterial hospital-acquired conditions.
Imipenem demonstrates potent bactericidal activity against a broad range of gram-positive and gram-negative bacterial pathogens, while Cilastatin prevents enzymatic breakdown of Imipenem in the kidneys, increasing antibacterial stability and therapeutic effectiveness. The injectable combination is commonly selected in ICU antibacterial protocols involving resistant bacterial organisms.
As a trusted Imipenem & Cilastatin Injection Manufacturer in India, Genliva Wellness LLP supplies sterile carbapenem formulations for hospital procurement agencies, emergency healthcare providers, institutional pharmaceutical buyers, and international injectable export markets.
Imipenem & Cilastatin Injection is formulated for advanced hospital antibacterial therapy.
This injectable formulation is prescribed in severe bacterial infection management.
Imipenem & Cilastatin Injection delivers high-potency carbapenem antibacterial therapy for critical infections.